chr14-57391526-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM1BP4_ModerateBS2
The NM_001011713.3(NAA30):c.569C>T(p.Ser190Phe) variant causes a missense change. The variant allele was found at a frequency of 0.000057 in 1,613,616 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00028 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000034 ( 1 hom. )
Consequence
NAA30
NM_001011713.3 missense
NM_001011713.3 missense
Scores
7
12
Clinical Significance
Conservation
PhyloP100: 5.18
Genes affected
NAA30 (HGNC:19844): (N-alpha-acetyltransferase 30, NatC catalytic subunit) Enables peptide alpha-N-acetyltransferase activity. Involved in N-terminal peptidyl-methionine acetylation. Located in cytosol and nucleus. Part of NatC complex. Colocalizes with polysome. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
PM1
In a modified_residue Phosphoserine (size 0) in uniprot entity NAA30_HUMAN
BP4
Computational evidence support a benign effect (MetaRNN=0.0880242).
BS2
High AC in GnomAd4 at 42 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NAA30 | NM_001011713.3 | c.569C>T | p.Ser190Phe | missense_variant | 2/5 | ENST00000556492.6 | NP_001011713.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NAA30 | ENST00000556492.6 | c.569C>T | p.Ser190Phe | missense_variant | 2/5 | 1 | NM_001011713.3 | ENSP00000452521.1 | ||
NAA30 | ENST00000298406.6 | c.204+20C>T | intron_variant | 1 | ENSP00000298406.6 | |||||
NAA30 | ENST00000554703.1 | c.-4+821C>T | intron_variant | 1 | ENSP00000451255.1 | |||||
NAA30 | ENST00000555166.5 | c.-4+821C>T | intron_variant | 2 | ENSP00000450939.1 |
Frequencies
GnomAD3 genomes AF: 0.000276 AC: 42AN: 152256Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
42
AN:
152256
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000724 AC: 18AN: 248694Hom.: 0 AF XY: 0.0000518 AC XY: 7AN XY: 135210
GnomAD3 exomes
AF:
AC:
18
AN:
248694
Hom.:
AF XY:
AC XY:
7
AN XY:
135210
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000342 AC: 50AN: 1461360Hom.: 1 Cov.: 31 AF XY: 0.0000385 AC XY: 28AN XY: 726984
GnomAD4 exome
AF:
AC:
50
AN:
1461360
Hom.:
Cov.:
31
AF XY:
AC XY:
28
AN XY:
726984
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000276 AC: 42AN: 152256Hom.: 0 Cov.: 33 AF XY: 0.000215 AC XY: 16AN XY: 74380
GnomAD4 genome
AF:
AC:
42
AN:
152256
Hom.:
Cov.:
33
AF XY:
AC XY:
16
AN XY:
74380
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
12
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2023 | The c.569C>T (p.S190F) alteration is located in exon 2 (coding exon 1) of the NAA30 gene. This alteration results from a C to T substitution at nucleotide position 569, causing the serine (S) at amino acid position 190 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Benign
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Benign
Sift
Benign
T
Sift4G
Uncertain
D
Polyphen
P
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at